Qube Research & Technologies (QRT)
RNAM

Qube Research & Technologies (QRT)’s Avidity Biosciences RNAM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,105,830
Closed -$79.8M – 4031
2025
Q4 		$79.8M Buy
+1,105,830
New +$71.4M 0.08% 323
2025
Q1 		– Sell
-223,759
Closed -$6.51M – 3817
2024
Q4 		$6.51M Buy
+223,759
New +$9.35M 0.01% 1346
2023
Q4 		– Sell
-59,771
Closed -$381K – 4674
2023
Q3 		$381K Buy
59,771
+46,845
+362% +$404K ﹤0.01% 2141
2023
Q2 		$143K Buy
+12,926
New +$162K ﹤0.01% 1873
2022
Q4 		– Sell
-29,758
Closed -$486K – 2912
2022
Q3 		$486K Buy
+29,758
New +$569K ﹤0.01% 1474

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Qube Research & Technologies (QRT)'s RNAM Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 1,105,830 shares — an estimated $79.8M sold.

Qube Research & Technologies (QRT) first reported a position in RNAM in Q3 2022 and held it in 5 quarters. The position peaked at $79.8M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,105,830 Avidity Biosciences shares in Q1 2026, an estimated $79.8M.
  • Qube Research & Technologies (QRT) first reported a position in Avidity Biosciences in Q3 2022 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Avidity Biosciences position peaked at $79.8M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.